Myriad decision aftershocks ripple through biotech – Nature.com
By Dr. Matthew Watson
Myriad decision aftershocks ripple through biotech Nature.com “That's one reading of the case,” says Hans Sauer of the Biotechnology Industry Organization (BIO) in Washington, DC. But a broad interpretation could extend the Court's logic to other molecules, he says. Indeed, its reasoning could translate pretty ... |
Uncategorized
Comments Off on Myriad decision aftershocks ripple through biotech – Nature.com |
August 25th, 2013
This author published 6012 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research